Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
St. Jude Children's Research Hospital |
---|---|
Information provided by: | St. Jude Children's Research Hospital |
ClinicalTrials.gov Identifier: | NCT00705497 |
Background: This prospective study was designed to be the first to evaluate the toxicity of radiofrequency ablation (RFA) in patients with recurrent pediatric solid tumors.
Methods: From 2003 through 2006, we conducted a phase I, IRB-approved study of RFA for recurrent solid tumors. A multidisciplinary cancer management team selected appropriate candidates for the study. Imaging-guided RFA was performed percutaneously. Response was assessed at 3 months. Repeat RFA was performed for some incompletely ablated or new lesions.
Condition | Intervention | Phase |
---|---|---|
Primary Tumors Metastatic Tumors |
Procedure: Radiofrequency Tumor Ablation |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Radiofrequency Ablation of Tumors (RFA) A Phase I Study |
Enrollment: | 31 |
Study Start Date: | January 2003 |
Estimated Study Completion Date: | October 2008 |
Estimated Primary Completion Date: | October 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental |
Procedure: Radiofrequency Tumor Ablation
Radiofrequency tumor ablation (RFA) is an imaging guided percutaneous or intra-operative procedure that uses a probe on the end of a sharp needle that is inserted directly into the tumor. The tumor is ablated by heating the probe (using electrical current alternating at radio frequency) which raises the temperature of the tumor potentially causing irreversible cell death.
|
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
General
Hepatic lesions
Musculoskeletal lesions
Lung lesions
United States, Tennessee | |
St. Jude Children's Research Hospital | |
Memphis, Tennessee, United States, 38105 |
Principal Investigator: | Matthew Krasin, MD | St. Jude Children's Research Hospital |
Responsible Party: | St. Jude Children's Research Hospital ( Matthew Krasin MD ) |
Study ID Numbers: | RFA |
Study First Received: | June 24, 2008 |
Last Updated: | June 25, 2008 |
ClinicalTrials.gov Identifier: | NCT00705497 |
Health Authority: | United States: Institutional Review Board |
Radiofrequency tumor ablation RFA |
Neoplasm Metastasis |
Neoplasms Neoplastic Processes Pathologic Processes |